Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zihan Shi

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|December 28, 2024
Discovery of an Efficacious RET PROTAC Degrader with Enhanced Antiproliferative Activity against Resistant Cancer Cells Harboring RET Solvent-Front MutationsQian Zhang, Yingqi He, Danni Rao, et al.
Journal of Medicinal Chemistry|November 28, 2025
Structure-Based Development of a Novel Macrocyclic Peptide to Disrupt the Lumican-Collagen I Interaction in Liver FibrosisXianzhi Wei, Haonan Li, Jiali Cao, et al.
Bioorganic Chemistry|December 30, 2023
Discovery of a potent and selective covalent threonine tyrosine kinase (TTK) inhibitorYaoliang Sun, Zhiwen Chen, Guobin Liu, et al.
Journal of Medicinal Chemistry|July 11, 2024
Discovery of Novel Peptide Antagonists Targeting GPR55 for Liver Inflammation and FibrosisZihan Shi, Xianyan Liu, Shuohan Wu, et al.
ACS Applied Materials & Interfaces|March 3, 2021
In Vitro and In Vivo Demonstration of Ultraefficient and Broad-Spectrum Antibacterial Agents for Photodynamic Antibacterial ChemotherapyQicai Xiao, Bingjie Mai, Yichu Nie, et al.
ACS Applied Materials & Interfaces|September 21, 2022
Correction to "In Vitro and In Vivo Demonstration of Ultraefficient and Broad-Spectrum Antibacterial Agents for Photodynamic Antibacterial Chemotherapy"Qicai Xiao, Bingjie Mai, Yichu Nie, et al.
Journal of Medicinal Chemistry|April 8, 2024
Design and Synthesis of Novel Ultralong-Acting Peptides as EDP-EBP Interaction Inhibitors for Pulmonary Fibrosis TreatmentYixiang Wang, Fanghan Xue, Wei Cheng, et al.
BMC Medical Imaging|May 9, 2026
A human-AI collaborative workflow for improved gross tumor volume delineation in esophageal cancer radiotherapyHongfei Sun, Jie Li, Yufen Liu, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 16, 2025
Lactylation: the regulatory code of cellular life activity and a barometer of diseasesXuebing Xu, Xuming Wu, Dandan Jin, et al.
International Immunopharmacology|July 6, 2026
ANXA11 recruits tumor-associated neutrophils to promote the progression of colorectal cancerDandan Jin, Junpeng Zhao, Weisong Xu, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|December 28, 2024
Discovery of an Efficacious RET PROTAC Degrader with Enhanced Antiproliferative Activity against Resistant Cancer Cells Harboring RET Solvent-Front MutationsQian Zhang, Yingqi He, Danni Rao, et al.
Journal of Medicinal Chemistry|November 28, 2025
Structure-Based Development of a Novel Macrocyclic Peptide to Disrupt the Lumican-Collagen I Interaction in Liver FibrosisXianzhi Wei, Haonan Li, Jiali Cao, et al.
Bioorganic Chemistry|December 30, 2023
Discovery of a potent and selective covalent threonine tyrosine kinase (TTK) inhibitorYaoliang Sun, Zhiwen Chen, Guobin Liu, et al.
Journal of Medicinal Chemistry|July 11, 2024
Discovery of Novel Peptide Antagonists Targeting GPR55 for Liver Inflammation and FibrosisZihan Shi, Xianyan Liu, Shuohan Wu, et al.
ACS Applied Materials & Interfaces|March 3, 2021
In Vitro and In Vivo Demonstration of Ultraefficient and Broad-Spectrum Antibacterial Agents for Photodynamic Antibacterial ChemotherapyQicai Xiao, Bingjie Mai, Yichu Nie, et al.
ACS Applied Materials & Interfaces|September 21, 2022
Correction to "In Vitro and In Vivo Demonstration of Ultraefficient and Broad-Spectrum Antibacterial Agents for Photodynamic Antibacterial Chemotherapy"Qicai Xiao, Bingjie Mai, Yichu Nie, et al.
Journal of Medicinal Chemistry|April 8, 2024
Design and Synthesis of Novel Ultralong-Acting Peptides as EDP-EBP Interaction Inhibitors for Pulmonary Fibrosis TreatmentYixiang Wang, Fanghan Xue, Wei Cheng, et al.
BMC Medical Imaging|May 9, 2026
A human-AI collaborative workflow for improved gross tumor volume delineation in esophageal cancer radiotherapyHongfei Sun, Jie Li, Yufen Liu, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 16, 2025
Lactylation: the regulatory code of cellular life activity and a barometer of diseasesXuebing Xu, Xuming Wu, Dandan Jin, et al.
International Immunopharmacology|July 6, 2026
ANXA11 recruits tumor-associated neutrophils to promote the progression of colorectal cancerDandan Jin, Junpeng Zhao, Weisong Xu, et al.
Pageof 5